FDA Approved Peptides List (2026): Complete Safety Guide The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Tesamorelin FDA Approval Status 2026: Egrifta, Clinical Trials & Research Injectable and Topical Peptides in Aesthetic Medicine Mechanisms, Clinical Applications, and Future Potential PRIME Journal